Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy

Clinical Trial ID NCT03734952

Rank	Title	Journal	Year	PubWeight™‹?›
1	Preoperative chemoradiotherapy for esophageal or junctional cancer.	N Engl J Med	2012	15.43
2	Cancer statistics in China, 2015.	CA Cancer J Clin	2016	12.92
3	Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.	J Clin Oncol	2009	4.38
4	Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial.	Eur J Cancer	2011	1.54
5	Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.	Dis Esophagus	2009	0.98
6	Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.	Dis Esophagus	2017	0.75
7	Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial.	Eur J Cancer	2017	0.75
8	Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.	Cancer	2017	0.75